Nanotechnology and tumor imaging: Seizing an opportunity

Daniel C. Sullivan, Mauro Ferrari

Research output: Contribution to journalReview articlepeer-review

56 Scopus citations


Nanoparticles, labeled with a signaling moiety for in vivo imaging, and one or more ligands for molecularly targeted specificity, hold considerable promise in oncology. Nanoparticles can serve as modular platforms, from which a wide variety of highly sensitive and specific imaging agents can be created. For example, many hundreds or thousands of atoms that provide imaging signals, such as radioisotopes, lanthanides, or fluorophores, can be attached to each nanoparticle, to form imaging agents that would provide higher sensitivity that can be obtained from agents based on small molecules. Similarly, many copies of targeted ligands can be attached to nanoparticles to markedly inrease specific binding. Drugs or therapeutic isotopes can be added to create multifunctional nanoparticles. Appropriately labeled and targeted nanoparticles could lead to a paradigm change in which cancer detection, diagnosis, and therapy are combined in a single molecular complex.

Original languageEnglish (US)
Pages (from-to)364-369
Number of pages6
JournalMolecular imaging
Issue number4
StatePublished - Oct 2004


  • Cancer
  • Early detection
  • Molecular imaging
  • Nanotechnology
  • Noninvasive

ASJC Scopus subject areas

  • Engineering(all)


Dive into the research topics of 'Nanotechnology and tumor imaging: Seizing an opportunity'. Together they form a unique fingerprint.

Cite this